Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.

Braakman, E; Schuurhuis, G J; Preijers, F W M B; Voermans, C; Theunissen, K; van Riet, I; Fibbe, W E; Slaper-Cortenbach, I

Braakman, E; Schuurhuis, G J; Preijers, F W M B; Voermans, C; Theunissen, K; van Riet, I; Fibbe, W E; Slaper-Cortenbach, I.

Affiliation

Braakman E; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands. e.braakman@erasmusmc.nl

Cytotherapy ; 10(1): 83-9, 2008.

Article in En | MEDLINE | ID: mdl-18202977

Subject(s)

Antigens, CD34/immunology; Hematopoietic Stem Cells/cytology; Hematopoietic Stem Cells/immunology; Leukapheresis/methods; Flow Cytometry; Humans; Leukapheresis/economics; Leukapheresis/instrumentation; Lymphocyte Depletion; Reproducibility of Results; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cells / Leukapheresis / Antigens, CD34 Type of study: Evaluation_studies / Observational_studies Limits: Humans Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google